Ad26.preF-based RSV vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ad26.preF-based RSV vaccine, covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older [Phase 1]